VBI VACCINES INC. (TSE:VBV) Files An 8-K Other Events


VBI VACCINES INC. (TSE:VBV) Files An 8-K Other Events
Item 8.01 Other Events.

On March 12, 2018, VBI Vaccines Inc. issued a press release announcing that it has applied to voluntarily delist its common shares from the Toronto Stock Exchange. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Press Release dated March 12, 2018

VBI Vaccines Inc/BC Exhibit
EX-99.1 2 ex99-1.htm       VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange   CAMBRIDGE,…
To view the full exhibit click here


VBI Vaccines Inc. is a development-stage biotechnology company. The Company’s principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company’s subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

An ad to help with our costs